These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37760399)

  • 1. Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme.
    Alizadeh M; Broomand Lomer N; Azami M; Khalafi M; Shobeiri P; Arab Bafrani M; Sotoudeh H
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients.
    Baine M; Burr J; Du Q; Zhang C; Liang X; Krajewski L; Zima L; Rux G; Zhang C; Zheng D
    J Imaging; 2021 Jan; 7(2):. PubMed ID: 34460616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review.
    Sidibe I; Tensaouti F; Roques M; Cohen-Jonathan-Moyal E; Laprie A
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T
    Sun YZ; Yan LF; Han Y; Nan HY; Xiao G; Tian Q; Pu WH; Li ZY; Wei XC; Wang W; Cui GB
    BMC Med Imaging; 2021 Feb; 21(1):17. PubMed ID: 33535988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation.
    Lohmann P; Elahmadawy MA; Gutsche R; Werner JM; Bauer EK; Ceccon G; Kocher M; Lerche CW; Rapp M; Fink GR; Shah NJ; Langen KJ; Galldiks N
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33353180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoprogression in high-grade glioma.
    Knudsen-Baas KM; Moen G; Fluge Ø; Storstein A
    Acta Neurol Scand Suppl; 2013; (196):31-7. PubMed ID: 23190289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of radiomics and machine learning for radiotherapy of malignant brain tumors.
    Kocher M; Ruge MI; Galldiks N; Lohmann P
    Strahlenther Onkol; 2020 Oct; 196(10):856-867. PubMed ID: 32394100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Evidence, Limitations and Future Challenges of Survival Prediction for Glioblastoma Based on Advanced Noninvasive Methods: A Narrative Review.
    García-García S; García-Galindo M; Arrese I; Sarabia R; Cepeda S
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556948
    [No Abstract]   [Full Text] [Related]  

  • 11. The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma.
    Xi J; Hassan B; Katumba RGN; Khaddour K; Govindan A; Luo J; Huang J; Campian JL
    BMC Cancer; 2021 Mar; 21(1):285. PubMed ID: 33726710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis.
    Ricciardi L; Sturiale CL; Scerrati A; Stifano V; Somma T; Ius T; Trungu S; Acqui M; Raco A; Miscusi M; Della Pepa GM
    Front Oncol; 2022; 12():848036. PubMed ID: 35252015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudoprogression: relevance with respect to treatment of high-grade gliomas.
    Fink J; Born D; Chamberlain MC
    Curr Treat Options Oncol; 2011 Sep; 12(3):240-52. PubMed ID: 21594589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patients.
    Voss M; Franz K; Steinbach JP; Fokas E; Forster MT; Filipski K; Hattingen E; Wagner M; Breuer S
    J Neurooncol; 2019 Mar; 142(1):161-169. PubMed ID: 30604393
    [TBL] [Abstract][Full Text] [Related]  

    Gryazov AB; Medvedovska YV; Gryazov AA
    Wiad Lek; 2020; 73(10):2160-2164. PubMed ID: 33310940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.
    Nasseri M; Gahramanov S; Netto JP; Fu R; Muldoon LL; Varallyay C; Hamilton BE; Neuwelt EA
    Neuro Oncol; 2014 Aug; 16(8):1146-54. PubMed ID: 24523362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of
    Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
    Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudoprogression after glioma therapy: an update.
    Galldiks N; Kocher M; Langen KJ
    Expert Rev Neurother; 2017 Nov; 17(11):1109-1115. PubMed ID: 28862482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.